A 2019 analysis by Market Research Reports report cited by Tetra Bio-Pharma, the global companion animal healthcare market is expected to be worth US$67 billion by the end of 2025. Things are looking good for Tetra Bio-Pharma Inc. as it prepares to conduct new research into the windows to our souls… and those of our furry companions. Subscribe to the Cannabis Post newsletter for weekly insights into the industry, what insiders will be talking about and content from across the Postmedia Network. Want to keep up to date on what’s happening in the world of cannabis? Health Canada granted approval to Panag Pharma to conduct the tests in 2019 and both companies have been busy since then preparing for the trials.
Things are looking good for Tetra Bio-Pharma Inc. as it prepares to conduct new research into the windows to our souls… and those of our furry companions.
University of Guelph research trial to explore the effect of cannabis on canine cancer Partnership meant to fill gaps on cannabis consumption risks and benefits with hard...Read the full article @ The Growth Op